Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01783197
Title Study of Selumetinib in Patients With Previously Treated or Untreated Advanced/Metastatic NSCLC
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors NCIC Clinical Trials Group|AstraZeneca
Indications

lung non-small cell carcinoma

Therapies

Selumetinib

Age Groups: adult
Covered Countries CAN


No variant requirements are available.